Opinion
Video
Author(s):
Panelists discuss how their clinical experiences with topical ruxolitinib are shaping new treatment paradigms for vitiligo, while also addressing challenges related to medication access.
Patients with DIMIDs and Pandemic Risks
The Cutaneous Connection: Enhancing Vitiligo Care With Nanette Silverberg, MD
Breaking Barriers in Pediatric Vitiligo Treatment
ReV Up Your Vitiligo Treatment Strategies
What’s New in the Medicine Chest: Vitiligo
Noninvasive Imaging Is Transforming Vitiligo Monitoring With OCT Technology